HealthLeaders Media January 15, 2021
Last Friday, Clover had its SPAC IPO on the Nasdaq, opening with a stock price of $15.30.
Clover Health, the Nashville-based technology-oriented Medicare Advantage company, made its long-awaited public debut on Wall Street last week.
In October, Social Capital Hedosophia Holdings Corp. III, a Silicon Valley-based special purpose acquisition company (SPAC), announced a plan to merge with Clover in a reported $3.7 billion deal. Last Friday, Clover had its SPAC IPO on the Nasdaq, opening with a stock price of $15.30.
Andrew Toy, president and chief technology office at Clover, spoke with HealthLeaders this week about the company’s public debut, what its growth plans for 2021 entail, and his advice for healthcare technology leaders looking ahead to opportunities after the...
Today's Sponsors
Today's Sponsor